|
Since 1996, Mr. Janney has been a managing director of Alta Partners, a venture capital firm investing in information technologies and life sciences companies and was a co-founder of the Alta BioPharma effort. Mr. Janney rejoined Anesiva’s board in February of 2008, after having previously served on the board from November 2000 through December 2005, when he transitioned off the board following the merger of Anesiva and AlgoRx Pharmaceuticals. In addition to Anesiva, he currently serves on the board of directors of a number of companies, including Acureon Pharmaceuticals, Alba Therapeutics, ChemGenex Pharmaceuticals, Kemia, Phenomix Corporation and ViroBay. He has been directly involved in the funding and development of over 25 life sciences companies. Previously, Mr. Janney was a senior investment banker at Montgomery Securities focusing on life science companies, prior to which he was at Bankers Trust Company in its leveraged buyout/private equity group. Mr. Janney received a B.A. in History from Georgetown University and an M.B.A. from the Anderson School at the University of California, Los Angeles. | 